Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OneMedNet (ONMD) Preferred Stock Liabilities (2021 - 2023)

OneMedNet has reported Preferred Stock Liabilities over the past 3 years, most recently at $19.2 million for Q3 2023.

  • Quarterly Preferred Stock Liabilities fell 84.01% to $19.2 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $19.2 million through Sep 2023, down 84.01% year-over-year, with the annual reading at $17.6 million for FY2022, 84.96% down from the prior year.
  • Preferred Stock Liabilities was $19.2 million for Q3 2023 at OneMedNet, down from $29.9 million in the prior quarter.
  • Over five years, Preferred Stock Liabilities peaked at $120.1 million in Q3 2022 and troughed at $17.6 million in Q4 2022.
  • The 3-year median for Preferred Stock Liabilities is $73.6 million (2021), against an average of $71.2 million.
  • Year-over-year, Preferred Stock Liabilities tumbled 84.96% in 2022 and then tumbled 74.72% in 2023.
  • A 3-year view of Preferred Stock Liabilities shows it stood at $117.3 million in 2021, then tumbled by 84.96% to $17.6 million in 2022, then rose by 8.87% to $19.2 million in 2023.
  • Per Business Quant, the three most recent readings for ONMD's Preferred Stock Liabilities are $19.2 million (Q3 2023), $29.9 million (Q2 2023), and $29.3 million (Q1 2023).